NEW! Subscribe to Medtech Pro and get one or all of our reports, plus much more.

May Emerging Medical Technologies Report

29 Pages | 30 Exhibits |
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now

Overview

This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in May 2014. Additionally, read LSI's "Innovator of the Month" Interview with:

- Amir Belson, M.D.

All companies include technology, market(s), key executive, and contact information.

Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies

This report may be purchased separately or is automatically provided to subscribers of LSI's Emerging Medical Technologies® Database.

 

Table of Contents

BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED

  • 1-Single cell gene expression and genome sequencing; 2-non-invasive tests for heart transplant rejection, and 3-approaches to sequence and analyze an individual's immune system
  • A device for use in scarless laparoscopic procedures
  • A diagnostic technology designed to greatly improve the speed and accuracy of Western blot, a technique widely used in molecular biology labs
  • A minimally invasive implant for the treatment of Obstructive Sleep Apnea (OSA)
  • A non-surgical implant to divert bile fluids and help in the resolution of type 2 diabetes
  • A novel hemostatic device capable of stopping high-flow arterial bleeding from non-compressible wounds, for use in treating life-threatening wounds on the battlefield
  • A system for hysteroscopic intrauterine tissue removal, including fibroids (myomas) and polyps
  • A tiny, battery-less implantable neurostimulator that can electrically control the nerves of the tongue and prevent airway blockage, in the treatment of sleep apnea and snoring
  • Allograft technology to be used with autogenous bone graft material and supplemental fixation for the treatment of complex orthopedic and neurological spinal disorders
  • An easy-to-use trocar with a built-in closure device, for use in laparoscopic surgery procedures
  • Angioplasty dual-balloon system to address the limitations of currently used PTA balloons in the treatment of peripheral vascular disease
  • Biomaterial for use in ocular surface repair; suitable for battlefield blast wound injuries and the growing elective phorefractive keratectomy procedure market
  • Blood pressure device used in screening for peripheral artery occlusive disease via measurement of Ankle Brachial Pressure Index
  • Breast cancer detection tools that are non-radiological and affordable
  • Device for intubated hospital patients that prevents ventilator-associated pneumonia
  • Early detection, over-the-counter breast cancer test to identify protein in urine
  • High-throughput microfluidic chip platform for simple and effective delivery of material into cells
  • Low-cost, smarter pedicle probe for the accurate placement of pedicle screws in spinal fusion surgery
  • Minimally invasive, image-guided surgical tool for beating heart mitral valve repair
  • Non-invasive perfusion imaging technology for use in the early identification of poorly perfused tissue that has an increased risk for necrosis or delayed healing, both in and outside the operating room
  • Novel diagnostic products to support patient stratification personalized therapies and the clinical development of new drugs for the treatment of microbiome-related diseases such as inflammatory bowel diseases and metabolic diseases (diabetes and obesity)
  • Polymer-based liquid bandage product
  • Products to prevent acute cellular injury following an ischemic event or as a preventative adjunct in vascular surgery by employing therapeutic hypothermia
  • Regenerative medicine (musculoskeletal deficiencies) technologies and diagnostic medicine (oncology and cardiology)
  • Small, portable temperature control device to meet the needs of users of medications such as insulin
  • Targeted nanoparticle tumor ablation
  • Therapeutic temperature management technology to prevent or limit brain and tissue damage following an ischemic event
  • Ultrasound-based renal denervation system for the treatment of resistant hypertension
  • User-friendly, non-invasive glucose monitor that continuously tracks blood glucose levels and trends painlessly, in a wristwatch format
  • Vascular access products that address the need for a safe, reliable and robust means for hemodialysis administration